JP2018150269A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018150269A5 JP2018150269A5 JP2017046986A JP2017046986A JP2018150269A5 JP 2018150269 A5 JP2018150269 A5 JP 2018150269A5 JP 2017046986 A JP2017046986 A JP 2017046986A JP 2017046986 A JP2017046986 A JP 2017046986A JP 2018150269 A5 JP2018150269 A5 JP 2018150269A5
- Authority
- JP
- Japan
- Prior art keywords
- melissa extract
- msh
- alpha
- active ingredient
- agent according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000284 extract Substances 0.000 claims description 4
- 230000002401 inhibitory effect Effects 0.000 claims description 3
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017046986A JP2018150269A (ja) | 2017-03-13 | 2017-03-13 | αＭＳＨ（１−８）発現抑制剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017046986A JP2018150269A (ja) | 2017-03-13 | 2017-03-13 | αＭＳＨ（１−８）発現抑制剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2018150269A JP2018150269A (ja) | 2018-09-27 |
| JP2018150269A5 true JP2018150269A5 (uk) | 2019-12-26 |
Family
ID=63680101
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017046986A Pending JP2018150269A (ja) | 2017-03-13 | 2017-03-13 | αＭＳＨ（１−８）発現抑制剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2018150269A (uk) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7355518B2 (ja) * | 2019-03-29 | 2023-10-03 | 丸善製薬株式会社 | コウスイハッカ発酵液の製造方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007186457A (ja) * | 2006-01-13 | 2007-07-26 | Ichimaru Pharcos Co Ltd | トリプターゼ活性阻害剤およびその利用 |
| JP2014114241A (ja) * | 2012-12-10 | 2014-06-26 | Ichimaru Pharcos Co Ltd | プロオピオメラノコルチン発現抑制剤 |
-
2017
- 2017-03-13 JP JP2017046986A patent/JP2018150269A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022013612A (es) | Combinaciones de inhibidores de desmetilasa-1 especifica de lisina (lsd1) para el tratamiento de malignidades hematologicas. | |
| JP2015096530A5 (uk) | ||
| CY1126110T1 (el) | Παραγωγα βενζοϋδροξαμικου οξεος ως εκλεκτικοι αναστολε1σ του hdac6 | |
| RU2016146115A (ru) | Ингибитор мышечной атрофии, содержащий гликозид кверцетина | |
| NZ745210A (en) | Novel 2,3,5-substituted thiophene compound as protein kinase inhibitor | |
| MY163235A (en) | Pharmaceutical preparation containing pyridylaminoacetic acid compound | |
| MD3482754T2 (ro) | Compoziții farmaceutice și utilizări direcționate spre tulburări de stocare lizozomale | |
| WO2015017393A3 (en) | Piperazine derivatives as hiv protease inhibitors | |
| WO2016057413A3 (en) | Inhibitors of lysine gingipain | |
| WO2015160907A3 (en) | Potent and selective inhibitors of hepatitis c virus | |
| WO2015126129A3 (ko) | C형 간염 바이러스의 게놈 복제의 선택적 저해 활성을 갖는 레스베라트롤 다량체 및 이의 용도 | |
| JP2018150269A5 (uk) | ||
| WO2016178510A3 (ko) | 진세노사이드 Ｆ1 또는 Ｒｇ3를 유효성분으로 포함하는 글리벡 내성 백혈병 예방 또는 치료용 약학 조성물 | |
| WO2016118882A8 (en) | Fragrance and flavor compositions comprising neopentyl glycol diacetate | |
| JP2018150270A5 (uk) | ||
| JP2014237635A5 (uk) | ||
| EA201890477A1 (ru) | Инкапсулированная композиция финголимода | |
| JP2014159408A5 (uk) | ||
| JP2017155062A5 (uk) | ||
| MX371492B (es) | Mezclas de sustancias. | |
| UY38043A (es) | Combinación farmacéutica que comprende tramadol clorhidrato de liberación extendida y etoricoxib de liberación inmediata, y su uso para el tratamiento del dolor | |
| PH12016502527B1 (en) | Stabilized desmopressin | |
| JP2017014205A5 (uk) | ||
| UA115290U (xx) | Композиція у формі спрею для орального застосування, що містить холіну альфосцерат | |
| WO2014176551A3 (en) | Pharmaceutical compositions containing vanoxerine and p450 inhibitors and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals through administration of said compositions |